Safety first
Guide / Research briefs

UV Exposure and Melanoma in Skin of Color: Evaluating the Systematic Evidence

Published October 28, 2026 · MTI Editorial Team · Sources linked on this page

!
Educational information only. Not medical advice and no dosing information. Melanotan I and II sold online are not FDA-approved. Talk to a licensed doctor.
UV Exposure and Melanoma in Skin of Color: What the Science Shows

Public health messaging around melanoma frequently centers on ultraviolet radiation from the sun and artificial tanning beds. However, dermatological researchers have increasingly questioned whether this primary causal model applies identically across all skin tones. Understanding how melanoma presents in deeply pigmented skin requires a careful review of clinical literature rather than assumptions borrowed from studies on fair complexion.

Scope and Design of the 2021 Systematic Review

To examine the relationship between sunlight and skin cancer across diverse populations, a systematic review titled "UV Exposure and the Risk of Cutaneous Melanoma in Skin of Color: A Systematic Review" was published in JAMA Dermatology. The investigators sought to critically assess and synthesize published scientific data analyzing ultraviolet exposure as a potential risk factor for cutaneous melanoma in individuals with skin of color.

Researchers conducted a comprehensive literature search across the PubMed, Cochrane, and Web of Science databases from inception through June 3, 2020. The authors defined skin of color broadly to include any race or ethnicity other than non-Hispanic White, individuals classified as Fitzpatrick skin types IV through VI, or individuals whose self-reported tanning response indicates that they rarely or never experience sunburns. After screening database records, 548 full-text articles were closely reviewed, and 13 individual studies met the formal inclusion criteria.

The design of these 13 included studies was observational: 7 were ecological investigations, 5 were cohort studies, and 1 was a case-control study. In total, the datasets encompassed more than 7700 melanomas diagnosed in people categorized by race or ethnicity within skin-of-color populations.

What the Systematic Review Found

The primary finding of the review challenged traditional public assumptions regarding sun exposure. Of the 13 studies meeting inclusion criteria, 11 identified no statistically significant association between ultraviolet exposure and the development of cutaneous melanoma in skin of color. The evaluated measures of exposure varied across studies and included the ambient UV index, geographic latitude, solar irradiance, a personal history of medical phototherapy, and a recorded history of sunburns.

Only two papers showed any correlation. One study identified a small positive relationship specifically in Black males, and another identified a weak association among Hispanic males. Because the vast majority of analyzed research found no link, the authors reported in JAMA Dermatology that the available evidence suggests UV exposure may not serve as an important primary risk factor for melanoma development in people with deeply pigmented skin. Consequently, widespread public health recommendations that emphasize sun avoidance as the primary mechanism for melanoma prevention in skin of color are not supported by the majority of published studies reviewed.

Biological Melanin and Anatomical Patterns

The divergent findings between fair and deeply pigmented skin tie directly into cutaneous biology. Epidermal melanocytes generate two primary types of pigment: eumelanin and pheomelanin. Individuals with naturally darker complexions produce higher amounts of eumelanin, which provides natural cellular photoprotection against solar radiation. Light-skinned individuals produce higher amounts of pheomelanin, which does not provide this protection.

Because eumelanin filters ultraviolet light effectively, melanoma in deeply pigmented skin frequently appears in areas that receive little or no sun exposure. As outlined in research on different types of skin cancer, the most prevalent form of melanoma diagnosed in individuals with darker skin tones—including people of African ancestry—is acral lentiginous melanoma. Unlike superficial spreading tumors that appear on the torso, arms, or legs after repeated sun damage, acral lentiginous lesions develop on non-sun-exposed surfaces such as the palms of the hands, the soles of the feet, and beneath the fingernails or toenails.

What the Study Does Not Prove

While the findings provide an important corrective to oversimplified messaging, it is vital not to overstate what this systematic review demonstrates. The review does not prove that ultraviolet radiation carries zero health consequences for darker skin, nor does it prove that individuals with skin of color can never develop sun-induced malignancies.

Crucially, the authors evaluated study quality using criteria from the Oxford Centre for Evidence-Based Medicine and found that all 13 included studies were of moderate to low quality, carrying Oxford ratings between 2b and 4. Observational and ecological designs cannot fully eliminate confounding factors or confirm precise individual exposures over a lifetime. The authors emphasized that further high-quality research is required before drawing definitive clinical conclusions.

Furthermore, these findings provide no justification for using unregulated tanning products. Unapproved substances such as melanotan I or melanotan II, often distributed illegally online, lack verified purity, pose documented health hazards, and should never be used to alter skin pigmentation.

Key Clinical Takeaways

A balanced interpretation of the systematic evidence supports targeted vigilance rather than a one-size-fits-all approach to dermatologic care:

  • Acknowledge study design limits: The systematic review in JAMA Dermatology reflects observational data of moderate to low quality, pointing to a need for deeper investigation.
  • Look beyond sun-exposed areas: Because acral lentiginous melanoma develops on palms, soles, and subungual nail beds, self-examinations should systematically inspect these non-exposed sites.
  • Avoid unregulated peptides: Injectable tanning peptides sold on black markets remain unapproved by regulatory agencies and carry unpredictable medical risks.
  • Consult a dermatologist: Any new, changing, dark, or irregular spot on the skin or under a nail warrants immediate clinical evaluation by a physician.

Sources

UV Exposure and the Risk of Cutaneous Melanoma in Skin of Color: A Systematic Review. - JAMA Dermatology / PubMed

Published October 28, 2026. Sources are linked in the text. See our Medical Disclaimer.